Literature DB >> 10027447

A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock.

I Alía1, A Esteban, F Gordo, J A Lorente, C Diaz, J A Rodriguez, F Frutos.   

Abstract

OBJECTIVE: To evaluate the effects of increased oxygen delivery on mortality and morbidity.
DESIGN: Randomized, controlled trial.
SETTING: Medical-surgical ICU of a tertiary care hospital. PATIENTS: Sixty-three patients classified according to predetermined criteria as having severe sepsis or septic shock.
INTERVENTIONS: The patients were randomly assigned to one of two groups: the control group (n = 32) received conventional therapy with a normal targeted value of oxygen delivery, and the treatment group (n = 31) received therapy with a targeted oxygen delivery index (DO2I) value of > 600 mL/min/m2. The therapeutic approach to maintain BP, arterial saturation, hemoglobin concentration, and pulmonary artery occlusion pressure was similar in both groups.
MEASUREMENTS AND MAIN RESULTS: The hemodynamic, oxygen transport, and gastric intramucosal pH measurements were recorded at the time of admission to the study and every 6 h for the next 96 h. The outcome measures were the rate of patient mortality and the number of organ dysfunctions occurring during the ICU stay. The study groups were similar with respect to demographics and admission hemodynamic variables, but the percentage of patients with positive blood cultures was significantly higher in the control group than in the treatment group, respectively: 34 vs 13% (p = 0.04). The average cardiac index was significantly higher in the treatment group than in the control group, respectively: 3.96 vs 3.05 L/min/m2 (p = 0.01). This factor did not significantly affect the DO2I. Nine of the 31 treatment group patients reached an average DO2I value of > 600 mL/min/m2. The rate of mortality in the control group patients up to the time of ICU discharge (66%) was similar to that seen in the treatment group (74%), respectively: 21 of 32 vs 23 of 31 (p = 0.46). The number of dysfunctional organs per patient was also similar in the control and treatment groups, respectively: 2.1+/-1.1 vs 2.6+/-1.2 (p = 0.12).
CONCLUSION: Treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock does not reduce mortality or morbidity.

Entities:  

Mesh:

Year:  1999        PMID: 10027447     DOI: 10.1378/chest.115.2.453

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Adjunctive Therapies for Sepsis and Septic Shock.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 2.  [Early goal-directed therapy in sepsis. Old wine in new skins?].

Authors:  M Bauer
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

Review 3.  What type of monitoring has been shown to improve outcomes in acutely ill patients?

Authors:  Gustavo A Ospina-Tascón; Ricardo L Cordioli; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

Review 4.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  The unknowns about oxygen therapy in critically ill patients.

Authors:  Rakshit Panwar
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.

Authors:  Massimo Antonelli; Mitchell Levy; Peter J D Andrews; Jean Chastre; Leonard D Hudson; Constantine Manthous; G Umberto Meduri; Rui P Moreno; Christian Putensen; Thomas Stewart; Antoni Torres
Journal:  Intensive Care Med       Date:  2007-04       Impact factor: 17.440

Review 7.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis.

Authors:  Alan E Jones; Michael D Brown; Stephen Trzeciak; Nathan I Shapiro; John S Garrett; Alan C Heffner; Jeffrey A Kline
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

8.  Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.

Authors:  Sarah J Beesley; Emily L Wilson; Michael J Lanspa; Colin K Grissom; Sajid Shahul; Daniel Talmor; Samuel M Brown
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

9.  Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Amalia Laderchi; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2008-11-18       Impact factor: 9.097

10.  Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial.

Authors:  Fernando Palizas; Arnaldo Dubin; Tomas Regueira; Alejandro Bruhn; Elias Knobel; Silvio Lazzeri; Natalio Baredes; Glenn Hernández
Journal:  Crit Care       Date:  2009-03-31       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.